Tuesday 20 April 2021
Home      All news      Contact us      RSS     
sputniknews.com - 2 month ago

India Prepares to Shun Britain s Oxford-AstraZeneca in Favour of Effective Domestic-Produced Covaxin

India has been slow to take advantage of the emergency approval of Covaxin, which received authorisation along with Oxford AstraZeneca in January. Emergency regulatory approval was granted the Indian vaccine while the third phase of the trial was still underway, but now preliminary data has revealed that it is 81 % effective.


Latest News
Hashtags:   

India

 | 

Prepares

 | 

Britain

 | 

Oxford

 | 

AstraZeneca

 | 

Favour

 | 

Effective

 | 

Domestic

 | 

Produced

 | 

Covaxin

 | 

Sources